2016 provisional data for the United States\u2022 Chikungunya virus disease became a nationally notifiable condition in 2015. Cases are reported to CDC by state and local health departments using standard case definitions.\u2022 As of November 22, 2016 ...
core
Development of a potential vaccine against dengue and chikungunya virus co-infection using immunoinformatics and structural evaluation. [PDF]
Ullah S +14 more
europepmc +1 more source
2016 provisional data for the United States\ue2\u20ac\ua2 Chikungunya virus disease became a nationally notifiable condition in 2015. Cases are reported to CDC by state and local health departments using standard case definitions.\ue2\u20ac\ua2 As of ...
core
RNA Capping, Replication Complex Assembly, and Translational Regulation in Chikungunya Virus: Molecular Mechanisms and Antiviral Opportunities. [PDF]
Patil RR, Pawar S, Patil S, Hinge DD.
europepmc +1 more source
Resurgence of Chikungunya virus: rising global threat and challenges in its mitigation. [PDF]
Sahu PS +8 more
europepmc +1 more source
Cocoa by-products extracts suppress viral replication and oxidative stress in chikungunya virus-infected cells. [PDF]
Morantes SJ +6 more
europepmc +1 more source
Development of Covalent Inhibitors of Chikungunya Virus nsP2 Cysteine Protease Enabled by Direct-to-Biology Synthesis and Screening. [PDF]
Cai Z +8 more
europepmc +1 more source
Impact of climate change on the global circulation of chikungunya virus: current evidence, future projections, and adaptation strategies. [PDF]
Wang C +6 more
europepmc +1 more source
Viral kinetics of the Chikungunya virus ESCA-MAL lineage during the 2025 Guangdong outbreak. [PDF]
He Y +8 more
europepmc +1 more source
Chikungunya virus TF inhibits SNX27-mediated endocytic recycling of GLUT1. [PDF]
Wang S, Zhang D, Zhang L.
europepmc +1 more source

